Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.
Danesin N, Lo Schirico M, Scapinello G, Grassi A, Riva M, Berno T, Branca A, Visentin A, Carraro M, Pavan L, Manni S, Bonaldi L, Martines A, Bertorelle R, Vianello F, Gurrieri C, Briani C, Zambello R, Trentin L, Piazza F. Danesin N, et al. Among authors: bertorelle r. Hemasphere. 2023 Oct 3;7(10):e964. doi: 10.1097/HS9.0000000000000964. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37799344 Free PMC article. No abstract available.
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
Castellani F, Visentin A, Schirinzi E, Salvalaggio A, Cacciavillani M, Candiotto C, Baratè C, Cellini A, Bertorelle R, Siciliano G, Trentin L, Briani C. Castellani F, et al. Among authors: bertorelle r. Neurol Neuroimmunol Neuroinflamm. 2023 May 3;10(4):e200122. doi: 10.1212/NXI.0000000000200122. Print 2023 Jul. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37137530 Free PMC article.
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Ermani M; GICNO. Brandes AA, et al. Among authors: bertorelle r. J Clin Oncol. 2006 Oct 10;24(29):4746-53. doi: 10.1200/JCO.2006.06.3891. Epub 2006 Sep 5. J Clin Oncol. 2006. PMID: 16954518 Clinical Trial.
Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancer.
Nicoletto MO, Bertorelle R, Borgato L, De Salvo GL, Artioli G, Lombardi G, Zustovich F, Marcato R, Parenti A, Montagna M, Donach ME. Nicoletto MO, et al. Among authors: bertorelle r. Int J Gynecol Cancer. 2009 Aug;19(6):1022-8. doi: 10.1111/IGC.0b013e3181a83cb5. Int J Gynecol Cancer. 2009. PMID: 19820363 Clinical Trial.
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.
Lombardi G, Zustovich F, Farina P, Fiduccia P, Della Puppa A, Polo V, Bertorelle R, Gardiman MP, Banzato A, Ciccarino P, Denaro L, Zagonel V. Lombardi G, et al. Among authors: bertorelle r. Anticancer Drugs. 2013 Jan;24(1):90-7. doi: 10.1097/CAD.0b013e32835aa5fd. Anticancer Drugs. 2013. PMID: 23075631 Review.
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.
Lombardi G, Rumiato E, Bertorelle R, Saggioro D, Farina P, Della Puppa A, Zustovich F, Berti F, Sacchetto V, Marcato R, Amadori A, Zagonel V. Lombardi G, et al. Among authors: bertorelle r. Am J Clin Oncol. 2015 Oct;38(5):514-9. doi: 10.1097/COC.0b013e3182a790ea. Am J Clin Oncol. 2015. PMID: 24064758 Clinical Trial.
91 results